↓ Skip to main content

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell…

Overview of attention for article published in Frontiers in Hematology, September 2024
Altmetric Badge

Mentioned by

twitter
1 X user